Sugi Predict

Sugi Predict / Compounds / SCHEMBL3022669

SCHEMBL3022669

SCHEMBL3022669

[CH2]C(O)COC(=O)c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.72
▸ ADRB2 P07550 2/20 0.57
▸ ADRB1 P08588 2/20 0.57
▸ ADRB3 P13945 2/20 0.57
▸ PRKCA P17252 1/20 0.56
▸ TDP1 Q9NUW8 2/20 0.55
▸ MAPK1 P28482 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ SLC6A2 P23975 1/20 0.53
▸ SLC6A3 Q01959 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ LMNA P02545 2/20 0.52
▸ SLC1A5 Q15758 1/20 0.50
▸ TSHR P16473 3/20 0.49
▸ F2 P00734 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ NPC1 O15118 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1030284 0.84 ALDH1A1 (1.00) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL13625428 0.84 ALDH1A1 (1.00) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL295042 0.84 ALDH1A1 (0.78) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL13217500 0.84 ALDH1A1 (0.78) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL1868286 0.84 ALDH1A1 (1.00) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL1862116 0.84 ALDH1A1 (1.00) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL8064782 0.84 ALDH1A1 (1.00) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL8023330 0.83 ALDH1A1 (0.65) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL12000806 0.82 ALDH1A1 (0.74) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL20236999 0.81 ALDH1A1 (0.62) ALDH1A1ADRB2ADRB1ADRB3PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197953-A9 LEVODOPA PRODRUGS, AND COMPOSITIONS AND USES THEREOF XENOPORT, INC. (US) 2010-08-05 — — US claimed
US-20090137834-A1 LEVODOPA PRODRUGS, AND COMPOSITIONS AND USES THEREOF XENOPORT, INC. (US) 2009-05-28 — — US claimed
US-7534813-B2 Levodopa prodrugs, and compositions and uses thereof XENOPORT, INC. (US) 2009-05-19 — — US claimed
US-7342131-B2 Levodopa prodrugs, and compositions and uses thereof XENOPORT, INC. (US) 2008-03-11 — — US claimed
EP-1751087-A1 LEVODOPA PRODRUGS, AND COMPOSITIONS AND USES THEREOF Xenoport, Inc. (US) 2007-02-14 — — EP claimed
WO-2005121069-A1 LEVODOPA PRODRUGS, AND COMPOSITIONS AND USES THEREOF XENOPORT, INC. (US) 2005-12-22 — — WO claimed
US-20050282891-A1 Levodopa prodrugs, and compositions and uses thereof WILSHIRE PHARMACEUTICALS, INC. 2005-12-22 — — US claimed
CN-109790391-B Curable resin composition for forming easily peelable film and method for producing same 大阪有机化学工业株式会社 2022-04-12 — — CN disclosed
US-11180585-B2 Film touch sensor and structure including the same DONGWOO FINE-CHEM CO., LTD. (KR) 2021-11-23 — — US disclosed
US-20210277156-A1 FILM TOUCH SENSOR AND STRUCTURE INCLUDING THE SAME DONGWOO FINE-CHEM CO., LTD. (KR) 2021-09-09 — — US disclosed
CN-111936573-A Curable resin composition for forming heat-resistant and easily peelable cured resin film, and method for producing same 大阪有机化学工业株式会社 2020-11-13 — — CN disclosed
CN-109564797-B Film touch sensor and structure including the same 东友精细化工有限公司 2020-06-26 — — CN disclosed
CN-109790391-A Curable resin composition for forming easily peelable film and method for producing same 大阪有机化学工业株式会社 2019-05-21 — — CN disclosed
EP-0467344-A1 Hindered amine light stabilizer hydrazides ELF ATOCHEM NORTH AMERICA, INC. (US) 1992-01-22 — — EP disclosed
EP-0409840-A4 BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES — 1991-09-04 — — EP disclosed
US-5041545-A 2-hydroxybenzophenone hydrazides and derivatives thereof ATOCHEM NORTH AMERICA, INC. (US) 1991-08-20 — — US disclosed
EP-0434080-A1 Derivatives of N-hals-substituted amic acid hydrazides ELF ATOCHEM NORTH AMERICA, INC. (US) 1991-06-26 — — EP disclosed
EP-0409840-A1 BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES ELF ATOCHEM NORTH AMERICA, INC. (US) 1991-01-30 — — EP disclosed
US-4980420-A Benzotriazole and oxanilide UV absorber hydrazides ATOCHEM NORTH AMERICA, INC. (US) 1990-12-25 — — US disclosed
WO-1990009369-A1 BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES ATOCHEM NORTH AMERICA, INC. (US) 1990-08-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197953-A9 LEVODOPA PRODRUGS, AND COMPOSITIONS AND USES THEREOF COMT, DDT, DDC ALDH1A1 504/4885ADRB2 1185/4885ADRB1 1145/4885
US-20050282891-A1 Levodopa prodrugs, and compositions and uses thereof COMT, DDT, DDC ALDH1A1 504/4885ADRB2 1185/4885ADRB1 1145/4885
US-20090137834-A1 LEVODOPA PRODRUGS, AND COMPOSITIONS AND USES THEREOF COMT, DDT, DDC ALDH1A1 504/4885ADRB2 1185/4885ADRB1 1145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.